SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-24-023061
Filing Date
2024-03-15
Accepted
2024-03-15 16:16:52
Documents
162

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0200030-03.htm   iXBRL F-1/A 14501171
7 GRAPHIC takanda_logo.jpg GRAPHIC 62930
8 GRAPHIC tflowchart_001.jpg GRAPHIC 156222
9 GRAPHIC tgreengrowth_logo.jpg GRAPHIC 36159
10 GRAPHIC tgreengrowth_sign.jpg GRAPHIC 36878
  Complete submission text file 0001213900-24-023061.txt   52445782

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE akan-20230630.xsd EX-101.SCH 204243
3 XBRL CALCULATION FILE akan-20230630_cal.xml EX-101.CAL 59540
4 XBRL DEFINITION FILE akan-20230630_def.xml EX-101.DEF 845023
5 XBRL LABEL FILE akan-20230630_lab.xml EX-101.LAB 1143485
6 XBRL PRESENTATION FILE akan-20230630_pre.xml EX-101.PRE 857074
164 EXTRACTED XBRL INSTANCE DOCUMENT ea0200030-03_htm.xml XML 14503580
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-277182 | Film No.: 24754997
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)